The USFDA inspected the Pharmaceutical Technology Centre (PTC), the company's state-of-the-art R&D facility located at Ahmedabad, dedicated to new product development of various niche dosage forms including solid oral, parenteral, pulmonary, oncology, ointment & creams and transdermal, from 18th March to 22nd March 2019.
At the end of the inspection, no observations (483) have been issued.
Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.336.2 as compared to the previous close of Rs. 337.3. The total number of shares traded during the day was 26945 in over 381 trades.
The stock hit an intraday high of Rs. 341.7 and intraday low of 336.2. The net turnover during the day was Rs. 9131873.